BACKGROUND: Oxidative stress has been recently suggested to play a part in the development of osteoporosis. Catalase is a major antioxidant enzyme that detoxifies hydrogen peroxide by converting it into water and oxygen, thereby preventing cellular injury by oxidative stress. AIMS: To examine the associations between the catalase gene (CAT) polymorphisms and bone mineral density (BMD) and bone turnover markers in postmenopausal Korean women. METHODS: All exons, their boundaries and the promoter region (approximately 1.5 kb) were directly sequenced in 24 individuals. Among 18 variants identified by a direct sequence method, four polymorphisms were selected and genotyped in all study participants (n = 560). BMD at the lumbar spine and proximal femur was measured using dual-energy x ray absorptiometry. Serum osteocalcin concentrations and bone-specific alkaline phosphatase activity were determined by an immunoradiometric assay and an immunoassay, respectively. RESULTS: The mean (standard deviation) age of the participants was 59.4 (7.2) years. Multivariate analysis showed an association of the +22348C-->T polymorphism with BMD at the lumbar spine (p = 0.01 in the dominant model) and at femur neck (p = 0.05 in the dominant model), and with serum osteocalcin level (p = 0.008 in the dominant model). Haplotype analyses showed that HT4 (-20T, +144C, +22348T, +33078A) was significantly associated with higher BMD at various sites (p<0.001-0.03) and with lower serum osteocalcin levels (p = 0.01 in the codominant model). CONCLUSIONS: These findings indicate that the +22348C-->T polymorphism and HT4 of CAT may be useful genetic markers for bone metabolism.
BACKGROUND: Oxidative stress has been recently suggested to play a part in the development of osteoporosis. Catalase is a major antioxidant enzyme that detoxifies hydrogen peroxide by converting it into water and oxygen, thereby preventing cellular injury by oxidative stress. AIMS: To examine the associations between the catalase gene (CAT) polymorphisms and bone mineral density (BMD) and bone turnover markers in postmenopausal Korean women. METHODS: All exons, their boundaries and the promoter region (approximately 1.5 kb) were directly sequenced in 24 individuals. Among 18 variants identified by a direct sequence method, four polymorphisms were selected and genotyped in all study participants (n = 560). BMD at the lumbar spine and proximal femur was measured using dual-energy x ray absorptiometry. Serum osteocalcin concentrations and bone-specific alkaline phosphatase activity were determined by an immunoradiometric assay and an immunoassay, respectively. RESULTS: The mean (standard deviation) age of the participants was 59.4 (7.2) years. Multivariate analysis showed an association of the +22348C-->T polymorphism with BMD at the lumbar spine (p = 0.01 in the dominant model) and at femur neck (p = 0.05 in the dominant model), and with serum osteocalcin level (p = 0.008 in the dominant model). Haplotype analyses showed that HT4 (-20T, +144C, +22348T, +33078A) was significantly associated with higher BMD at various sites (p<0.001-0.03) and with lower serum osteocalcin levels (p = 0.01 in the codominant model). CONCLUSIONS: These findings indicate that the +22348C-->T polymorphism and HT4 of CAT may be useful genetic markers for bone metabolism.
Authors: Antonis Goulas; Liana Fidani; Alexandros Kotsis; Vassiliki Mirtsou; Ronald C Petersen; Eric Tangalos; John Hardy Journal: Neurosci Lett Date: 2002-09-20 Impact factor: 3.046
Authors: D A Chistiakov; K V Savost'anov; R I Turakulov; E V Titovich; L I Zilberman; T L Kuraeva; I I Dedov; V V Nosikov Journal: Diabetes Metab Res Rev Date: 2004 May-Jun Impact factor: 4.876
Authors: Xiao-chun Bai; Di Lu; Jie Bai; Hang Zheng; Zi-yong Ke; Xiao-ming Li; Shen-qiu Luo Journal: Biochem Biophys Res Commun Date: 2004-01-30 Impact factor: 3.575
Authors: Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu Journal: Genomics Date: 2009-01-14 Impact factor: 5.736
Authors: Mona El Refaey; Christopher P Watkins; Eileen J Kennedy; Andrew Chang; Qing Zhong; Ke-Hong Ding; Xing-ming Shi; Jianrui Xu; Wendy B Bollag; William D Hill; Maribeth Johnson; Monte Hunter; Mark W Hamrick; Carlos M Isales Journal: Mol Cell Endocrinol Date: 2015-01-28 Impact factor: 4.102
Authors: Na Tao; Lianhong Li; Qing Chen; Zhongming Sun; Qinglin Yang; Dafang Cao; Xun Zhao; Fangfang Zeng; Jun Liu Journal: Front Public Health Date: 2022-05-13